Evaluation of antioxidant deficit in schizophrenia

Aim: Oxidative stress is a state in which there is disequilibrium between pro-oxidant processes and the antioxidant defense system in favor of the former and occurs as a consequence of increased production of free radicals or when the antioxidant defense system is inefficient or a combination of both events. A disturbance in the antioxidant defense system, including antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSHPx), due to free radical-induced oxidative injury has also been implicated in various neuropsychiatric disorders. Hence the role of these antioxidant enzymes and the changes in their level in blood and correlation with oxidative stress and the overall mechanism of defense were studied in a common psychiatric illness, schizophrenia. Materials and Methods: Fifty subjects of either sex ranging in age from 18 to 60 years, divided into two age groups (< 40 years and >40 years), diagnosed for schizophrenia; and 50 age- and sex-matched normal subjects as controls were included in the study. Blood samples were collected for the determination of malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSHPx), and reduced glutathione (GSH). Results: Significantly lower levels of the two antioxidant enzymes were found in schizophrenics compared to normal controls, with an increased oxidative stress as indicated by high blood MDA levels. The condition worsened with advancing age, smoking, among literate masses, and in chronic schizophrenics; whereas gender did not show any effect. Conclusion: It can be concluded that an imbalance in the antioxidant defense system, along with enzymatic antioxidants, occurs in schizophrenia due to the persistent oxidative stress. Modern life style perhaps also contributes to the condition.

[1]  J. Knight,et al.  The biochemistry of aging. , 2000, Advances in clinical chemistry.

[2]  I. Altuntaş,et al.  Erythrocyte Superoxide Dismutase and Glutathione Peroxidase Activities, and Malondialdehyde and Reduced Glutathione Levels in Schizophrenic Patients , 2000, Clinical chemistry and laboratory medicine.

[3]  Sandhya Mishra,et al.  Oxidative stress, α-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics , 2006, Indian Journal of Clinical Biochemistry.

[4]  Yan Shen,et al.  Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics , 2006, Schizophrenia Research.

[5]  A. Bast,et al.  Oxidants and antioxidants: state of the art. , 1991, The American journal of medicine.

[6]  Ömer Akyol,et al.  The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  S. Stohs,et al.  The Role of Free Radicals in Toxicity and Disease , 1995, Journal of basic and clinical physiology and pharmacology.

[8]  U. Bandyopadhyay,et al.  Reactive oxygen species: oxidative damage and pathogenesis , 1999 .

[9]  J. Stocks,et al.  The Autoxidation of Human Red Cell Lipids Induced by Hydrogen Peroxide , 1971, British journal of haematology.

[10]  S. Mukherjee,et al.  Free radical pathology and antioxidant defense in schizophrenia: a review , 1996, Schizophrenia Research.

[11]  S. Mahadik,et al.  Oxidative injury and potential use of antioxidants in schizophrenia. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.

[12]  Ganesh Dakhale,et al.  Oxidative Damage and Schizophrenia: The Potential Benefit by Atypical Antipsychotics , 2004, Neuropsychobiology.

[13]  M. Cuénod,et al.  Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia , 2003, Schizophrenia Research.

[14]  C. Fendri,et al.  Implication du stress oxydant dans la physiopathologie de la schizophrénie: revue de la littérature. , 2006 .

[15]  H. Canatan,et al.  Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder , 2002, Cell biochemistry and function.

[16]  P. Ranjekar,et al.  Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients , 2003, Psychiatry Research.